Markers for prenatal diagnosis and monitoring of trisomy 21

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2601735

Methods and kits are provided for diagnosing, monitoring, or predicting preeclaimpsia in a pregnant woman, trisomy 18 and trisomy 21 in a fetus, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more RNA species derived from a set of genetic loci and comparing the amount of the RNA species with a standard control.

L~invention concerne des procédés et des kits pour diagnostiquer, surveiller et prédire une néphropathie gravidique chez la femme enceinte, de la trisomie 18 et de la trisomie 21 chez le fAEtus, ainsi que pour déceler une grossesse chez la femme, en mesurant quantitativement la quantité d~une ou plusieurs espèces d'ARN issues d~un ensemble de loci génétiques dans le sang maternel et en comparant cette quantité à un témoin de référence.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Markers for prenatal diagnosis and monitoring of trisomy 21 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Markers for prenatal diagnosis and monitoring of trisomy 21, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Markers for prenatal diagnosis and monitoring of trisomy 21 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1715291

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.